CVA Family Office LLC decreased its position in MetLife, Inc. (NYSE:MET – Get Rating) by 52.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,045 shares of the financial services provider’s stock after selling 1,140 shares during the quarter. CVA Family Office LLC’s holdings in MetLife were worth $66,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Norges Bank bought a new stake in MetLife during the 4th quarter worth about $430,368,000. Bank of New York Mellon Corp grew its holdings in MetLife by 93.3% during the 1st quarter. Bank of New York Mellon Corp now owns 11,393,164 shares of the financial services provider’s stock worth $800,713,000 after acquiring an additional 5,499,871 shares during the last quarter. Adage Capital Partners GP L.L.C. grew its holdings in MetLife by 164.2% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 2,461,926 shares of the financial services provider’s stock worth $153,846,000 after acquiring an additional 1,530,000 shares during the last quarter. Viking Global Investors LP bought a new stake in MetLife during the 1st quarter worth about $95,733,000. Finally, Envestnet Asset Management Inc. grew its holdings in MetLife by 95.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,582,973 shares of the financial services provider’s stock worth $181,531,000 after acquiring an additional 1,258,042 shares during the last quarter. Institutional investors own 86.53% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have commented on MET. Barclays set a $75.00 price objective on shares of MetLife in a report on Tuesday, July 19th. JPMorgan Chase & Co. cut their target price on shares of MetLife from $75.00 to $74.00 in a research report on Monday, July 11th. Citigroup assumed coverage on shares of MetLife in a research report on Monday, May 23rd. They set a “buy” rating and a $77.00 target price on the stock. Evercore ISI upped their target price on shares of MetLife to $81.00 in a research report on Tuesday, August 9th. Finally, Credit Suisse Group upped their target price on shares of MetLife from $68.00 to $77.00 and gave the company an “outperform” rating in a research report on Monday, August 22nd. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $76.92.
Insiders Place Their Bets
MetLife Stock Performance
Shares of NYSE:MET opened at $66.28 on Tuesday. The company has a market capitalization of $53.90 billion, a price-to-earnings ratio of 16.49, a P/E/G ratio of 0.49 and a beta of 1.05. The firm’s 50 day simple moving average is $64.26 and its 200 day simple moving average is $65.58. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.13 and a quick ratio of 0.13. MetLife, Inc. has a fifty-two week low of $57.05 and a fifty-two week high of $73.18.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 14th. Shareholders of record on Tuesday, August 9th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, August 8th. This represents a $2.00 annualized dividend and a yield of 3.02%. MetLife’s dividend payout ratio (DPR) is currently 49.75%.
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
- Get a free copy of the StockNews.com research report on MetLife (MET)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.